Oligonucleotide-Cyclopropapyrroloindole Conjugates
J. Am. Chem. Soc., Vol. 119, No. 27, 1997 6223
(110 mg, 0.48 mmol) and EDC (300 mg, 1.56 mmol). After being
stirred for 30 min, the mixture was cooled in ice and water (15 mL)
was added. The resulting solid was collected by filtration, washed with
water, and dried in Vacuo. The crude product was purified by flash
chromatography CH2Cl2-MeOH (20:1) to give (1S)-9a as an off-white
solid after evaporation of the solvent (95 mg, 73%): 1H NMR (CDCl3)
δ 8.96 (br s, 1H), 8.04 (s, 1H), 6.73 (s, 1H), 4.54 (br s, 1H), 4.28 (d,
1H, J ) 11 Hz), 4.13 (t, 1H, J ) 8 Hz), 4.02 (s, 3H), 3.93 (m, 1H),
3.84 (m, 1H), 3.31 (t, 1H, J ) 11 Hz), 3.15 (m, 2H), 2.7-2.4 (m, 2H),
2.37 (s, 3H), 1.83 (m, 2H), 1.7-1.4 (m, 4H overlapping with H2O and
BOC), 1.43 (s, 9H). Anal. Calcd for C24H34N3O4Cl‚0.3H2O: C, 61.41;
H, 7.43; N, 8.95. Found: C, 61.66; H, 7.30; N, 8.61.
(1S)-3-(3-(N-(tert-Butyloxycarbonyl)amino)propanoyl)-1-(chlo-
romethyl)-6,8-dimethyl-1,2-dihydro-3H-pyrrolo[3,2-e]indol-5-ol ((1S)-
10a). Compound (1S)-10a was synthesized by analogy with (1S)-9a
using 3-(N-BOC-amino)propanoic acid in 83% yield: 1H NMR (CDCl3)
δ 8.69 (br s, 1H), 7.99 (s, 1H), 6.74 (s, 1H), 5.53 (br s, 1H), 4.25 (d,
1H, J ) 11 Hz), 4.11 (t, 1H, J ) 8 Hz), 4.02 (s, 3H), 3.93 (m, 1H),
3.85 (m, 1H), 3.60 (m, 2H), 3.33 (t, 1H, J ) 11 Hz), 3.0-2.6 (m, 2H),
2.37 (s, 3H), 1.42 (s, 9H). Anal. Calcd for C21H28N3O4Cl: C, 59.78;
H, 6.69; N, 9.96. Found: C, 59.88; H, 6.59; N, 9.56.
(200 mg, 2 mmol) and triethylamine (0.5 mL, 3.65 mmol), and the
resulting solution was stirred for 3 h. The solvents were removed by
evaporation, and the crude product was purified by flash chromatog-
raphy (CH2Cl2-MeOH-triethylamine, 90:10:2) to give the desired
succinate (1S)-16 as a tan solid foam (200 mg, 50%). It was dissolved
in a mixture of acetonitrile (10 mL), triethylamine (3 mL), and water
(3 mL). After being stirred for 45 min, the mixture was concentrated
in Vacuo. Residual water was removed by coevaporation with
acetonitrile (3 × 10 mL). The resulting cyclic product (8aS)-18a (tan
oil) was taken to the next step without additional purification. To a
solution of the crude succinate ((8aS)-18a) in 5 mL of dry CH2Cl2 were
added dropwise triethylamine (200 mL) and 2,3,5,6-tetrafluorophenyl
trifluoroacetate27 (200 mL, 1.14 mmol). After being stirred for 1 h,
the solution was concentrated in Vacuo. Flash chromatography (3.5 ×
15 cm, 40% ethyl acetate-hexane) afforded (8aS)-18b (180 mg) as a
white crystalline solid (150 mg, 74% from (8aS)-18a): mp 158-160
°C (hexane/ethyl acetate): 1H NMR (CDCl3) δ 7.00 (m, 1H), 6.58 (s,
1H), 4.4-4.1 (m, 1H), 3.99 (s with overlapping m, 4H), 3.3-2.7 (m,
5H), 1.98 (s, 3H), 1.92 (m, 1H), 1.22 (t, 1H, J ) 4.5 Hz). Anal. Calcd
for C23H18N2O4F4: C, 59.74; H, 3.92; N, 6.06. Found: C, 59.51; H,
3.72; N, 5.92. [R]22
: +112° (c 0.005, CDCl3). (8aR)-18b was
D
prepared analogously from (1R)-7b: [R]22D: -115° (c 0.004, CDCl3).
(8aS)-2,3,5,6-Tetrafluorophenyl 1,2,8,8a-tetrahydro-7-methyl-4-
oxo-cyclopropa[c]pyrrolo[3,2-e]indole-2-succinate ((8aS)-19b). It
was prepared by analogy with (8aS)-18b by starting from (1S)-3-(tert-
butyloxycarbonyl)-1-(chloromethyl)-5-hydroxy-8-methyl-1,2-dihydro-
3H-pyrrolo[3,2-e]indole ((1S)-15a)16,24,26 in 44% yield: 1H NMR
(CDCl3) δ 9.61 (br s, 1H), 7.00 (m, 1H), 6.85 (s, 1H), 4.4-3.9 (m,
2H), 3.3-2.8 (m, 5H), 2.03 (s, 3H), 1.99 (m, 1H), 1.27 (m, 1H). Anal.
Calcd for C22H16N2O4F4: C, 58.93; H, 3.60; N, 6.25. Found: C, 58.61;
H, 3.78; N, 5.98. (8aR)-19b was prepared analogously from (1R)-
15a.
(1S)-20a. To a solution of freshly prepared (1S)-7b (0.33 mmol) in
5 mL of dry DMA were added 3-(tert-butyloxycarbonyl)-1,2-dihydro-
3H-pyrrolo[3,2-e]indole-7-carboxylic acid28 (100 mg, 0.33 mmol) and
EDC (120 mg, 0.63 mmol). After being stirred for 5 h, the mixture
was cooled in ice and water (15 mL) was added. The resulting solid
was collected by filtration, washed with 1 M potassium phosphate and
water, and dried in Vacuo affording (1S)-20a as a green-yellow solid
(161 mg, 91%). This was 95% pure by reverse phase HPLC. An
analytical sample was purified by flash chromatography (5% MeOH
in CH2Cl2): 1H NMR (DMSO-d6) δ 11.62 (s, 1H), 9.79 (s, 1H), 7.8 (br
s, 1H), 7.61 (br s, 1H), 7.31 (d, 1H, J ) 9 Hz), 6.96 (br s, 2H), 4.63
(t, 1H, J ) 10 Hz), 4.50 (d, 1H, J ) 11 Hz), 4.1-3.8 (m with
overlapping singlet (CH3) at 3.92 ppm, 6H), 3.55 (t, 1H, 10 Hz), 3.4-
3.1 (m, 3H overlapping with the water peak), 2.31 (s, 3H), 1.51 (s,
9H). Anal. Calcd for C29H31N4O4Cl: C, 65.10; H, 5.84; N, 10.47.
Found: C, 64.86; H, 5.94; N, 10.26. (1R)-20a was prepared analo-
gously from (1R)-7b.
(1S)-21a. It was prepared by analogy with (1S)-20a starting from
(1S)-3-(tert-butyloxycarbonyl)-1-(chloromethyl)-5-hydroxy-8-methyl-
1,2-dihydro-3H-pyrrolo[3,2-e]indole ((1S)-15a) and 3-(tert-butyloxy-
carbonyl)-1,2-dihydro-3H-pyrrolo[3,2-e]indole-7-carboxylic acid. Crude
(1S)-21a was purified by flash chromatography in ethyl acetate to give
the title compound as a yellow-green solid (70% yield): 1H NMR
(DMSO-d6) δ 11.63 (s, 1H), 10.72 (s, 1H), 9.77 (s, 1H), 7.82 (m, 1H),
7.61 (m, 1H), 7.31 (d, 1H, J ) 9 Hz), 7.04 (s, 1H), 6.96 (s, 1H), 4.65
(t, 1H, J ) 10 Hz), 4.52 (d, 1H, J ) 11 Hz), 4.02 (t, 2H, J ) 8.5 Hz),
3.91 (d, 1H, J ) 8.5 Hz), 3.58 (t, 1H, 9 Hz), 3.4-3.1 (m, 3H
overlapping with the water peak), 2.35 (s, 3H), 1.52 (s, 9H). Anal.
Calcd for C28H29N4O4Cl: C, 64.55; H, 5.61; N, 10.75. Found: C,
64.33; H, 5.73; N, 10.46. (1R)-21a was prepared analogously from
(1R)-15a and 3-(tert-butyloxycarbonyl)-1,2-dihydro-3H-pyrrolo[3,2-e]-
indole-7-carboxylic acid.
(8aS)-22b. (1S)-20a (150 mg, 0.28 mmol) was suspended in 5 mL
of ethyl acetate saturated with HCl. The suspension was stirred for 40
min and concentrated in Vacuo. Residual HCl was removed by
coevaporation with CH2Cl2 (2 × 10 mL). The resulting orange solid
((1S)-20b) was dissolved in 1 mL of dry DMA. Succinic anhydride
(30 mg, 0.3 mmol) and triethylamine (50 mL, 0.36 mmol) were added
to produce succinate (1S)-20c. After being stirred for 3 h, the reaction
mixture was diluted with acetonitrile (10 mL) followed by the addition
(8aS)-2-6-((N-(Bromoacetyl)amino)hexanoyl)-1,2,8,8a-tetrahydro-
5,7-dimethylcyclopropa[c]pyrrolo[3,2-e]indol-4-one ((8aS)-11b). (1S)-
9a (80 mg, 0.17 mmol) was suspended in 3 mL of ethyl acetate saturated
with HCl. The suspension was stirred for 30 min and concentrated in
Vacuo. Residual HCl was removed by coevaporation with CH2Cl2 (2
× 10 mL). The resulting hydrochloride (1S)-9b was dissolved in a
mixture of acetonitrile (10 mL), triethylamine (3 mL), and water (3
mL). After 40 min, the solution was concentrated in Vacuo to give an
oil. This was dried by coevaporation with acetonitrile (3 × 10 mL) to
give (8aS)-11a as a tan solid (95% pure by analytical reverse phase
HPLC). To a suspension of the amine (8aS)-11a in 2 mL of DMF
were added triethylamine (50 mL) and bromoacetic acid N-hydroxy-
succinimide ester (50 mg, 0.21 mmol). After 30 min, the reaction
mixture was partitioned between water and CH2Cl2. The water layer
was separated and reextracted. The combined organic layer was washed
with 5% NaHCO3, dried over Na2SO4, and concentrated in Vacuo.
Chromatography on silica gel, eluting with 5% MeOH-CH2Cl2,
afforded 52 mg (68%) of (8aS)-11b as an off-white crystalline solid:
1H NMR (CDCl3) δ 6.66 (br s 1H), 6.57 (s, 1H), 4.3-3.8 (m, 7H),
3.35 (m, 2H), 2.85 (m, 1H), 2.52 (m, 2H), 1.98 (s, 3H), 1.92 (m, 1H),
1.73 (m, 2H), 1.59 (m, 2H), 1.43 (m, 2H), 1.16 (t, 1H, J ) 5 Hz).
Anal. Calcd for C21H26N3O3Br: C, 56.26; H, 5.85; N, 9.37. Found:
C, 56.55; H, 6.02; N, 9.45.
(8aS)-2-3-((N-(Bromoacetyl)amino)propanoyl)-1,2,8,8a-tetrahy-
dro-5,7-dimethylcyclopropa[c]pyrrolo[3,2-e]indol-4-one ((8aS)-12b).
(8aS)-12b was synthesized by analogy with (8aS)-11b in 62% yield:
1H NMR (CDCl3) δ 7.2 (br s 1H), 6.58 (s, 1H), 4.3-3.8 (m, 7H), 3.65
(m, 2H), 2.88 (m, 1H), 2.72 (m, 2H), 1.98 (s, 3H), 1.92 (m, 1H), 1.18
(m, 1H). Anal. Calcd for C18H20N3O3Br: C, 53.21; H, 4.96; N, 10.34.
Found: C, 53.41; H, 5.01; N, 10.57.
(8aS)-2-(Chloroacetyl)-1,2,8,8a-tetrahydro-5,7-dimethylcyclopro-
pa[c]pyrrolo[3,2-e]indol-4-one ((8aS)-14). To a solution of freshly
prepared (1S)-7b (0.28 mmol) in 3.5 mL of dry DMA were added
bromoacetic acid (100 mg, 0.72 mmol) and EDC (300 mg, 1.56 mmol).
After being stirred for 30 min, the solution was diluted with 10 mL of
acetonitrile. Triethylamine (3 mL) and water (3 mL) were added to
convert chloromethyl intermediate (1S)-13b into cyclic compound (8aS)-
14. After 1 h, acetonitrile was removed on a rotary evaporator. The
residual solution (∼6 mL) was diluted with 15 mL of brine and
extracted with dichloromethane (2 × 15 mL). The organic phase was
washed with 5% NaHCO3 (15 mL) and dried over Na2SO4. Purification
by flash chromatography (CH2Cl2-MeOH, 20:1) gave (8aS)-14 as an
off-white solid (21 mg, 22%): 1H NMR (CDCl3) δ 6.59 (s, 1H), 4.4-
4.0 (m, 4H), 3.98 (s, 3H), 2.87 (m, 1H), 1.98 (s, 3H), 1.95 (m, 1H,
partially overlapping with CH3 singlet), 1.23 (t, 1H, J ) 5 Hz). Anal.
Calcd for C15H15N2O2Cl: C, 61.97; H, 5.20; N, 9.64. Found: C, 61.67;
H, 5.14; N, 9.46.
(8aS)-2,3,5,6-Tetrafluorophenyl 1,2,8,8a-tetrahydro-5,7-dimethyl-
4-oxo-cyclopropa[c]pyrrolo[3,2-e]indole-2-succinate ((8aS)-18b). To
a suspension of freshly prepared (1S)-7b (0.9 mmol) in a mixture of
dry CH2Cl2 (7 mL) and MeOH (7 mL) were added succinic anhydride